New DTC Genetics Firm Pathway Genomics Launches | GenomeWeb

NEW YORK (GenomeWeb News) – Pathway Genomics, a new direct-to-consumer genetic testing firm, launched today, offering genotyping and analysis for disease risk and heredity for under $250.

The San Diego, Calif.-based company said that its on-site lab has been certified by California regulators and has received CLIA clearance. The company said its testing enables customers to learn about disease risk, adverse drug responses, carrier status, and ancestral history.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.